USD 0.1
(-0.21%)
Year | Revenue | Revenue Growth |
---|---|---|
2024 | 25.18 Million USD | 33.05% |
2023 | 18.93 Million USD | 358.01% |
2022 | 4.13 Million USD | 0.0% |
2021 | - USD | 0.0% |
2020 | - USD | 0.0% |
2019 | - USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q3 | 6.34 Million USD | 5.43% |
2024 Q4 | 7.33 Million USD | 15.6% |
2024 Q1 | 5.48 Million USD | -10.96% |
2024 Q2 | 6.02 Million USD | 9.81% |
2024 FY | 25.18 Million USD | 33.05% |
2023 FY | 18.93 Million USD | 358.01% |
2023 Q3 | 4.77 Million USD | 12.48% |
2023 Q2 | 4.24 Million USD | 13.2% |
2023 Q1 | 3.75 Million USD | -8.08% |
2023 Q4 | 6.15 Million USD | 28.92% |
2022 Q2 | 15.69 Thousand USD | 11.11% |
2022 Q4 | 4.08 Million USD | 18025.58% |
2022 FY | 4.13 Million USD | 0.0% |
2022 Q1 | 14.12 Thousand USD | 0.0% |
2022 Q3 | 22.51 Thousand USD | 43.47% |
2021 FY | - USD | 0.0% |
2021 Q2 | - USD | 0.0% |
2021 Q1 | - USD | 0.0% |
2021 Q4 | - USD | 0.0% |
2021 Q3 | - USD | 0.0% |
2020 Q2 | - USD | 0.0% |
2020 FY | - USD | 0.0% |
2020 Q4 | - USD | 0.0% |
2020 Q3 | - USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2019 Q1 | - USD | 0.0% |
2019 FY | - USD | 0.0% |
2019 Q4 | - USD | 0.0% |
2019 Q3 | - USD | 0.0% |
2019 Q2 | - USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2018 FY | - USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2017 FY | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 FY | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
China Pharma Holdings, Inc. | 7.01 Million USD | -259.22% |
cbdMD, Inc. | 24.15 Million USD | -4.267% |
cbdMD, Inc. | 24.15 Million USD | -4.267% |